PEDIALYTE POWDER PACKS OTC
Generic Name and Formulations:
Dextrose 5.7g, sodium 10.6Eq, potassium 4.7mEq, chloride 8.3mEq, Calories 23; per pack; contains acesulfame; apple, fruit punch, grape, or strawberry flavor.
Indications for PEDIALYTE POWDER PACKS:
Oral fluid and electrolyte replacement in mild to moderate diarrhea and vomiting.
Mix one pack with 8oz of water and drink. <1yr: not recommended. ≥1yr: Give every 1–4hrs; intake: 32–64oz/day.
As sole therapy in severe continuing diarrhea. Intractable vomiting. Adynamic ileus. Intestinal obstruction or perforated bowel. Anuria, oliguria, or impaired homeostatic mechanism.
Fluid & electrolyte replacement.
Liq (flavored)—1L; Liq (unflavored)—2oz, 1L; Singles (6.8oz)—16; Pwd (packets)—4, 8; Pops—16
Neurology Advisor Articles
- Case Study Report: Herbal Supplement Kratom Associated With Neonatal Abstinence Syndrome
- Seizure Monitoring Smartwatch Cleared for Use in Children
- Steps to Facilitate Rapid Reperfusion to Improve Poststroke Outcomes
- Ocrelizumab Reduces Upper Extremity Disability Progression Risk in PPMS
- Cerebellar Stimulation May Help Improve Gait and Balance Recovery in Stroke
- Very Early Mobilization After Stroke Does Not Improve Survival Over Usual Care
- Alemtuzumab Linked to Clinical and MRI Disease Remission in Multiple Sclerosis
- Cognitive Decline Worsens With Memantine, ChEIs in Patients With Alzheimer's
- Cervical Dysfunction Needs Clarification to Identify Link With Headache
- Levodopa Inhalation Powder Approved for Parkinson Disease
- Risk for Conversion of MS Varies With Different Therapies
- Breakdown of Blood-Brain Barrier May Drive Dementia
- FDA: Food Inspections to Resume Despite Ongoing Funding Lapse
- First Generic Version of Sabril Tablets Gets FDA Approval
- Supine Positioning After Greater Occipital Nerve Block May Improve Outcomes